Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
197.55
+1.18 (+0.60%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
59
60
Next >
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
August 23, 2024
Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,...
Via
Benzinga
Key Takeaways From AbbVie Analyst Ratings
August 23, 2024
Via
Benzinga
How To Build A Dividend Growth Portfolio In An Overpriced Market
August 22, 2024
The stock market as measured by the S&P is currently at an all-time high which makes it very challenging to try to build a quality dividend growth portfolio.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Unpacking the Latest Options Trading Trends in AbbVie
August 20, 2024
Via
Benzinga
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
August 20, 2024
Via
Benzinga
Decoding AbbVie's Options Activity: What's the Big Picture?
August 14, 2024
Via
Benzinga
Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
August 12, 2024
Crown Laboratories will acquire Revance Therapeutics for $924 million, paying $6.66 per share — a premium of 89%.
Via
Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
August 02, 2024
Via
Benzinga
3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More
August 18, 2024
These stocks dividends continue to flow and grow.
Via
The Motley Fool
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
August 18, 2024
This list of top-selling drugs could look drastically different in a few years.
Via
The Motley Fool
3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income
August 17, 2024
These stocks all pay more than 3%, and they have been regularly increasing their payouts in recent years.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
The 3 Best Stocks to Buy to Survive Another S&P 500 Crash
August 15, 2024
These three stocks to buy now will protect your portfolio if the S&P 500 crashes again regardless of whether there is a recession or not.
Via
InvestorPlace
Topics
Economy
Stocks
Exposures
Economy
US Equities
A Closer Look at AbbVie's Options Market Dynamics
July 31, 2024
Via
Benzinga
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Syros Pharmaceuticals announces discontinuing enrollment in the SELECT-AML-1 Phase 2 trial due to the low probability of demonstrating superiority. The trial evaluated tamibarotene with venetoclax and...
Via
Benzinga
3 Stocks Retirees Should Absolutely Love
August 10, 2024
All of these stocks can provide steady income to retired investors.
Via
The Motley Fool
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
August 08, 2024
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Warren Buffett's Approach To Investing In Election Years
August 07, 2024
Warren Buffett, known as the 'Oracle of Omaha', is a highly successful American investor who manages his portfolio consistently, regardless of elections or market conditions.
Via
Benzinga
Elliott Wave Technical Analysis: AbbVie Inc.
August 07, 2024
An in-depth look at ABBV's price movements using the Elliott Wave Theory, helping traders identify potential opportunities based on current trends and market structure.
Via
Talk Markets
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
August 06, 2024
Via
Benzinga
Large Cap Biopharma And Healthcare, A Port In A Storm
August 05, 2024
Healthcare and biopharma show nice gains in a volatile week.
Via
Talk Markets
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
August 05, 2024
Recent market pressure could worsen, but that won't stop these successful businesses from raising their dividend payouts.
Via
The Motley Fool
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
Via
Benzinga
Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early
July 31, 2024
The company reported $1.1 million in adjusted operating income, well ahead of expectations for a $2.6 million loss.
Via
Investor's Business Daily
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
July 31, 2024
Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates.
Via
InvestorPlace
7 Stocks Set for a Major Bull Run
July 31, 2024
Explore top stocks to buy, leading in social media, semiconductors, entertainment, restaurants, payments and biotechnology.
Via
InvestorPlace
3 Powerhouse Growth Stocks to Load Up On During This Bull Market Cycle
July 31, 2024
Here are three powerhouse growth stocks long-term investors may want to hone in on during this part of the market cycle.
Via
InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns.
Via
Benzinga
3 High-Yield Dividend Stocks That Are Looking Super Hot
July 29, 2024
Discover high-yield dividend stocks offering solid returns. Learn about AbbVie, Target, and Abbott for reliable income and growth potential.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.